Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Meridian Bioscience Inc.

    NASDAQ: VIVO · Real-Time Price · USD
    33.97
    0.00 (0.00%)
    At close: Jan 30, 2023, 10:00 PM

    Meridian Bioscience Balance Sheet Statement

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
    Cash & Equivalents
    		 74.1M 81.45M 83.49M 76.49M 72.73M 49.77M 70.01M 63.37M 63.19M
    Short-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 1.98M 2.08M 1.76M 1.59M 1.09M 365K 395K 465K -3.01M
    Receivables
    		 41.57M 47.23M 44.91M 59.22M 44.3M 53.57M 42.26M 44.9M 40.94M
    Inventory
    		 72.66M 67.81M 70.11M 70.93M 74.2M 76.84M 71.81M 72.53M 67.24M
    Other Current Assets
    		 13.2M 14.1M 13.97M 10.93M 12.43M 12.63M 10.9M 7.49M 6.24M
    Total Current Assets
    		 201.53M 210.6M 212.47M 217.56M 203.65M 192.81M 194.98M 188.29M 177.62M
    Property-Plant & Equipment
    		 51.46M 50.71M 49.85M 50.89M 48.72M 49M 51.06M 48.26M 35.99M
    Goodwill & Intangibles
    		 192.14M 190.43M 193.81M 193.1M 196.37M 198.82M 192.06M 194.13M 195.84M
    Total Long-Term Assets
    		 255.23M 252.5M 253.46M 254.25M 254.99M 256.92M 251.59M 250.88M 231.83M
    Total Assets
    		 456.76M 463.1M 465.93M 471.81M 458.64M 449.72M 446.57M 439.17M 409.45M
    Account Payables
    		 14.41M 17.76M 15.36M 15.68M 16.29M 11.7M 13.1M 16.71M 15.35M
    Deferred Revenue
    		 1.1M 667K 1.2M 675K 765K 638K 735K 608K 7.71M
    Short-Term Debt
    		 1.95M 1.83M 2.02M 2.13M 2.06M 1.99M 2.06M 1.89M 1.83M
    Other Current Liabilities
    		 61.11M 37.7M 41.76M 37.97M 30.83M 32.83M 20.8M 31.1M 28.93M
    Total Current Liabilities
    		 78.58M 57.95M 60.35M 56.47M 49.95M 47.16M 36.7M 50.31M 53.83M
    Long-Term Debt
    		 29.19M n/a 29.77M 30.58M 53.53M 63.93M 54.48M 54.55M 58.82M
    Other Long-Term Liabilities
    		 8.46M 31.89M 10.26M 10.13M 9.95M 4.1M 33.23M 24.83M 32.41M
    Total Long-Term Liabilities
    		 37.65M 37.09M 40.03M 40.71M 63.48M 74.26M 87.71M 79.39M 91.23M
    Total Liabilities
    		 116.22M 95.04M 100.38M 97.18M 113.42M 121.42M 124.41M 129.7M 145.06M
    Total Debt
    		 31.14M 30.96M 31.8M 32.71M 55.59M 65.92M 56.54M 56.45M 60.66M
    Common Stock
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Retained Earnings
    		 193.34M 223.16M 217.46M 224.79M 196.04M 180.7M 174.04M 162.38M 136.07M
    Comprehensive Income
    		 -7.07M -10.5M -5.89M -887K 555K 198K 1.81M 1.76M 1.4M
    Shareholders Equity
    		 340.54M 368.06M 365.55M 374.63M 345.22M 328.3M 322.16M 309.47M 278.87M
    Total Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a

    Add to Watchlist